These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2089403)

  • 1. Protection studies on anticholinesterase agents in rats.
    Das Gupta S; Bhattacharya R; Purnanand ; Pant BP
    Pharmazie; 1990 Oct; 45(10):801-2. PubMed ID: 2089403
    [No Abstract]   [Full Text] [Related]  

  • 2. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure?
    Lorke DE; Petroianu GA
    J Appl Toxicol; 2009 Aug; 29(6):459-69. PubMed ID: 19603416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myoneural conduction blockade by choline esters in the presence of cholinesterase inhibitors and restoration of conduction by cholinesterase reactivators].
    Protas LL
    Dokl Akad Nauk SSSR; 1973 Apr; 209(5):1243-6. PubMed ID: 4350639
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and structure-activity relationships of antidotes to organophosphorus anticholinesterase agents.
    Gray AP
    Drug Metab Rev; 1984; 15(3):557-89. PubMed ID: 6386410
    [No Abstract]   [Full Text] [Related]  

  • 7. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring exposure of passerines to acephate, dicrotophos, and malathion using cholinesterase reactivation.
    Maul JD; Farris JL
    Bull Environ Contam Toxicol; 2004 Oct; 73(4):682-9. PubMed ID: 15389333
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
    Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
    Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
    Kuca K; Jun D; Cabal J; Musilova L
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of oximes in the therapy of acute intoxication by organophosphorus compounds].
    Raszewski G; Filip R
    Przegl Lek; 2004; 61(3):181-4. PubMed ID: 15518329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on "Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6".
    Theirmann H; Worek F; Eyer P
    Toxicol Mech Methods; 2009 May; 19(4):334; author reply 335. PubMed ID: 19778225
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
    Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
    J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.